Anika Therapeutics, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year One
Anika Therapeutics, Inc. (ANIK) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $200.00 thousand as of 2025-03-31, per its 10-Q filed 2025-05-09.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2025-05-09
- 2025-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $200.00K.
- 2024-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $347.00K.
- 2024-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $274.00K.
- 2024-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $274.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2025-03-31 | $200.00K 10-Q · filed 2025-05-09 |
| 2024-09-30 | $347.00K 10-Q · filed 2024-11-04 |
| 2024-06-30 | $274.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $274.00K 10-Q · filed 2024-05-08 |
| 2019-12-31 | $900.00K 10-K · filed 2020-03-06 |
| 2018-12-31 | $1.00M 10-K · filed 2019-02-27 |
| 2017-12-31 | $1.00M 10-K · filed 2018-02-27 |
| 2016-12-31 | $900.00K 10-K · filed 2017-02-24 |
| 2015-12-31 | $1.00M 10-K · filed 2016-03-10 |
| 2014-12-31 | $1.00M 10-K · filed 2015-03-13 |
| 2012-12-31 | $2.00M 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |